Term
Acetylcholine is employed at? |
|
Definition
Most junctions of the PNS |
|
|
Term
Norepinephrine is released by? |
|
Definition
Most postganglionic neurons |
|
|
Term
Epinephrine is released by? |
|
Definition
|
|
Term
Chloinergic receptors are mediated by? |
|
Definition
|
|
Term
Adrenergic receptors are mediated by? |
|
Definition
Epinephrine and norepinephrine |
|
|
Term
Subtypes of cholinergic receptors? |
|
Definition
nicotinic n, nicotinic m, and muscarinic |
|
|
Term
subtypes of adrenergic receptors? |
|
Definition
Alpha1, alpha2, beta1, beta2, dopamine |
|
|
Term
|
Definition
vasoconstriction, ejaculation, contraction of bladder neck and prostate |
|
|
Term
|
Definition
located in presynaptic juction, minimal clinical significance, inhibits transmitter release |
|
|
Term
|
Definition
In the heart, increases heart rate, force of contraction, and velocity of conduction in AV noce
In the Kidney, releases renin |
|
|
Term
|
Definition
LUNGS: bronchial dilation, relaxation of uterine muscle, vasodilation, glycogenolysis (breakdown of glycogen which increases sugar in blood) |
|
|
Term
|
Definition
Dilates renal blood vessels |
|
|
Term
Epinephrine activates which receptors? |
|
Definition
all alpha and beta receptors, but not dopamine |
|
|
Term
Norephinephrine activates which receptors? |
|
Definition
alpha 1, alpha 2, beta 1, but not beta 2 or dopamine |
|
|
Term
Dopamine activates which receptors? |
|
Definition
alpha 1, beta 1, and dopamine receptors |
|
|
Term
Cholinesterase Inhibitors prevent breakdown of what? |
|
Definition
|
|
Term
|
Definition
muscarinic agonist
Used for urinary retention
Constricts bronchi and increased HR so dont use for patients with asthma, and hyperthyriod patients |
|
|
Term
|
Definition
muscarinic agonists
used in glaucoma: constricts pupils in eye which would decrease pressure |
|
|
Term
|
Definition
muscarinic antagonists (anticholinergic drugs)
Increases heart rate, decreases secretion from exocrine glands, relaxes bronchi, detrusor muscle and GI tract; causes mydriasis
Adverse Effects: dry mouth, blurred vision, increase intraocular pressure, urinary retention, constipation, anhidrosis, tachycardia, asthma |
|
|
Term
Chloninesterase Inhibitors |
|
Definition
Drugs that prevent the degradation of acetylcholine by acetylcholinesterase |
|
|
Term
|
Definition
"Reversible" Cholinesterase Inhibitors
Identical to muscarinic agonist response
Increases force of contraction in skeletal muscle, mild stimulation of the CNS
Used for Myasthenia gravis, used postoperatively to reverse muscle paralysis
Precaustions: Obstruction of GI Tract, Peptic ulcer disease, asthma, coronary insufficiency, hyperthyroidism |
|
|
Term
|
Definition
autoimmune disease; patient has periods of being ok then periods of fatigue
Treated with cholinesterase inhibitors |
|
|
Term
|
Definition
prevent acetylcholine from activating nicotinicM
cannot cross BBB |
|
|
Term
|
Definition
"Drug of choice for murder"
Ultrashort acting, muscle relaxation, no affect on the CNS
Adverse Effects: prolonged apnea in patients genetic tendency for slow acetylators, malignant hyperthermia, postoperative muscle pain, hyperkalemia
Drug Interactions: antibiotics potentiate succinylcholine (aminoglyosides,, tetracyclines |
|
|
Term
|
Definition
produce their effects by activating adrenergic receptors: sympathomimetic |
|
|
Term
|
Definition
Adrenergic agaonists
cannot be used orally, brief duration of action, cannot cross the BBB |
|
|
Term
|
Definition
Adrenergic Agonists
can be given orally, metabolized slowly by MAO (longer half life)
More able to cross BBB |
|
|
Term
Receptor for Terbutaline? |
|
Definition
|
|
Term
Receptor for Isoproterenol? |
|
Definition
|
|
Term
receptor for Epinephrine? |
|
Definition
Alpha 1 and alpha 2
Beta 1 and Beta 2 |
|
|
Term
|
Definition
vasoconstriction, hemostasis, nasal decongestion, adjunct to local anesthesia, elevation of BP
Drugs: epinephrine, norepinephrine, phenylephrine, ephedrine, dopamine
Adverse effects: hypertension, necrosis, bradycardia,
|
|
|
Term
|
Definition
Inhibits Norepinephrine release |
|
|
Term
|
Definition
works on cardiac arrest, heart failure (increases force of contraction), shock (increases HR), atrioventricular heart block (enhances conduction of AV node
adverse effects: altered HR or rhythm, angina pectoris (increases oxygen demand to heart by increasing HR and force of contraction) |
|
|
Term
|
Definition
for asthma but need to be specific, delay of preterm labor (relaaxes uterine smooth muscle
Adverse effects: hyperglycemia (promotes breakdown of glycogen into glucose), tremor (from activation of skeletal muscle) |
|
|
Term
|
Definition
severe allergic response
causes hypotension, bronchoconstriction, edema of glottis
Treat with epinephrine |
|
|
Term
|
Definition
adrenergic agonists
delay absorption of local anesthetic, control superficial bleeding, elevate BP, mydriasis during opthalmolocic procedures, overcome AV block, bronchial dilation in asthma, for anaphylactic shock
Adverse Effects: hypertensive crisis, dysrhythmias, angina, necrosis, hyperglycemia
Drug Interactions: MAO inhibitors, tricyclic antidepressants, alpha-adrenergic blocking agents, beta adrenergic blocking agents |
|
|
Term
|
Definition
Adrenergic agonist
Used for hypotensive states and cardiac arrest
does not activate beta 2 receptors
Does not promote hyperglycemia, cause necrosis with extravasation,
Drug interactions: MAOI, TCA, general anesthetics, adrenergic blocking agents |
|
|
Term
|
Definition
Adrenergic agonist
Receptor for beta 1 and beta 2
used for AV heart block and arrest, used for bronchodilation in asthma (not used anymore), bronchospasm during anesthesia
Adverse effects: tachydysrhythmias, angina pectoris, hyperglycemia
drug interactions: MAOI, TCA, beta adrenergic blockers |
|
|
Term
|
Definition
Adrenergic agonists
used of shock (increases cardiac output and renal perfusion), heart failure (increases contractility)
Adverse effects: tachycardia, dysrhythmias, anginal pain, necrosis with extravasation
Drug Interactions: MAIO, TCA, |
|
|
Term
|
Definition
adrenergic agonists
Beta 2 receptor
used in asthma (selective for beta 2)
adverse effects: minimal therapeutic doses, tremor, and tachycardia |
|
|
Term
|
Definition
cause direct blockade of adrenergic receptors, with one exception all produce reversible (competitive) blockade, more selective than adrenergic agonists
Two Groups: 1) alpha adrenergic blacking agents 2) beta adrenergic blocking agents |
|
|
Term
|
Definition
Used in hypertension (lowers BP), benign prostatic hyperplasia, Raynauds disease, orthostatic hypotension,
Adverse effects: nasal congestion, inhibition of ejaculation, sodium retention and increased blood volume
Drugs: prazosin, terazosin, doxazosin, tamsulosin, alfuzosin (***ends in ZOSIN) |
|
|
Term
Beta Adrenergic Antagonists
(Beta blockade) |
|
Definition
used in angina pectoris, hypertension cardiac dysrhythmias, MI, heart failure, hyperthyroidism, migraine, stage fright, glaucoma
Adverse effects of beta 1 blockade: bradycardia, reduced cardiac output, AV heart block,
Adverse effects of beta 2 blockade: bronchoconstriction, inhibition of glycogenolysis |
|
|
Term
|
Definition
beta adrenergic antagonists
blocks caardiac receptors (decreases cardiac output), non selective beta 1 and 2
used hypertension, angina, dysrhythmias, and MI
Adverse effects: bronchoconstriction, bradycardia, AV heart block, Heart failure, inhibition of glycogenolysis
Drug interactions: calcium channel blockers (diltiazem & verapamil) and insulin
Contraindictions: severe allergy, diabetes hypoglycemia, psychiatric disorders |
|
|
Term
Adrenergic neuron blocking agent |
|
Definition
Indirect acting antiadrenergic agent
decrease norepinephrine release |
|
|
Term
Centrally acting alpha 2 agonists |
|
Definition
Indirect acting antiadrenergic agent
reduce impulses along the sympathetic nerves |
|
|
Term
|
Definition
Indirect acting antiadrenergic agent: adrenergic neuron blocking agent
Depletion of NE from postganglionic sympathetic neurons, can cause depletion of transmitters, slows heart rate, reduces caardiac output, used in sedation and severe depression |
|
|
Term
|
Definition
indirect acting antiadrenergic agents: centrally acting alpha 2 agonists
used for hypertension by decreasing BP and pain, use din minimal orthostatic hypotension
adverse effects: drowsiness, xerostomia, rebound hypertension, |
|
|
Term
|
Definition
indirect acting antiadrenergic agents
lowers BP (in supine and standing) by acting at sites within the CNS, causes alpha 2 activation, vasodilation,
used for hypertension (no longer first line drug)
adverse effects: positive coombs test and hemolytic anemia, hepatotoxicity, orthostatic hypotension
|
|
|
Term
|
Definition
Neurodegenerative disorder of the extrapyramidal system associated with disruption of neurotransmission in the striatum
Imbalance between dopamine nad aCh
Characterized by: dyskinesias and akinesia |
|
|
Term
|
Definition
* most commonly used drugs for PD*
activate dopamine receptors
Ex: levodopa |
|
|
Term
|
Definition
used for PD
prevent activation of cholinergic receptors
EX: benztropine |
|
|
Term
|
Definition
dopaminergic agents
promotes dopamine synthesis
used in PD
rapid absorption of small intestine, good delays absorption, high protein foods reduce effect
Adverse effects: nausea and vomiting, dyskinesias, psychosis, darken sweat and uring, drug holidays
drug interactions: first generation antipsychotics, MAOI, anticholinergics, pyridoxine (Vit B6) |
|
|
Term
|
Definition
used for PD
no adverse effects, increases the available levodopa in CNS and allows decrease of levodopa dosage
effects come mainly from levodoopa when given in combo
levodopa/carbidopa= sinemet
Carbidopa alone is for investigational use |
|
|
Term
|
Definition
First line drugs for PD
direct activtion of dopamine receptors in striatum
compared to levodopa: less effective, dont compete with dietary proteins, lower incidence of response failure
Two types: 1) derivative of ergot (usually not used, nonselective) 2) nonergot derivates |
|
|
Term
Nonergot Dopamine Agonists |
|
Definition
Example: pramipexole (mirapex)
used alone in early PDand with levodopa in advanced stages of PD
also use din restless leg syndrome
Adverse effects: monotherapy=nausea, vomiting, insominia, weakness, constipation, hallucinations; combined= orthostatic hypotension and dyskinesias, and increase in hallucinations |
|
|
Term
|
Definition
selective reversible inhibitor of COMT
only for use with levopoda
increases levodopa availability by inhibiting COMT, which decreases production of levodopa metabolites that compete with levodopa for transport
Adverse effects: from the increasing levodopa levels |
|
|
Term
|
Definition
second and third line of use for PD
combo with levodopa can reduce the wearing off effect |
|
|
Term
|
Definition
MAO-B inhibitors
Inhibits dopamine breakdown
suppresses destructionof dopamine derived from levodopa and prolong the effects of levodopa
adverse effects: insomia when used alone |
|
|
Term
Cholinesterase inhibitors |
|
Definition
used with mild to moderate alhezimers
prevent breakdown of ach, may help slow progression of disease
Only three recommended: donepezil (aricept), galatamine, rivastigmine (exelon)
|
|
|
Term
|
Definition
first drugs in new class of NMDA areceptor antagonists
used for moderate to severe AD
Better tolerated than cholinesterase inhibitors
adverse effects: dizziness, headache, confusion, constipation and aviod use in patients with renal impairment |
|
|
Term
|
Definition
antiepileptic drug
selective inhibition of sodium channels
adverse effects: nystagmus, sedation, ataxia, diplopia, cognitive impairment, skin rash, birth defects
Drug interactions: decrease effects of oral contraceptives, warfarin, and glucocorticoids, increases levels of diazepam, isoniazid, cimetidine, alcohol, and valproic acid |
|
|
Term
|
Definition
Used for epilepsy, bipolar disorder, trigeminal and glossopharyngeal neuralgias
adverse effects: nystagmus, ataxia, leukopenia, anemia, thrombocytopenia birth defects, hypo-osmolarity, rash , photosensitivity NO GRAPEFRUIT JUICE |
|
|
Term
|
Definition
used for seizure disorders, bipolar disorder, migraine
adverse effects: gi effects, hepatotoxicity, pancreatitix, neural tube defects
|
|
|
Term
|
Definition
used for epilepsy, promotes sleep and sedation
replaced by newer drugs |
|
|
Term
|
Definition
Involuntary contraction of muscle or muscle group
Causes: epilepsy, hypocalcemia, pain syndroms, and trama |
|
|
Term
Centrally acting muscle relaxants |
|
Definition
relieve local muscle spasm, decrease local muscle paon, increase range of motion
one is not superior to the other
Adverse Effects: generalized CNS depression, hepatic toxicity, physical dependence
DOES NOT TREAT SPASTICITY |
|
|
Term
|
Definition
movement disorders of CNS origin
Most common causes: multiple sclerosis, and cerebral palsy
Characteristics: heightened muscle tone, spasm, loss of dexterity
Drugs: Baclofen, diazepam, dantrolene |
|
|
Term
|
Definition
acts in the CNS specifically the spinal cord, supresses hyperactive reflexes, many mimic the action of GABA on spinal neurons
Used for multiple sclerosis, spinal cord injury, cerebral palsy NOT WITH STROKE, supresses resistance to passive movement, no effect on skeletal muscle (used for spasticity)
Adverse effects: no antidote for overdose, gradual withdrawal, cns depressant, GI symptoms, urinary retention |
|
|
Term
|
Definition
Acts in CNS, member of the benzodiazepine family, the only one labeled to treat spasticity, mimics action of GABA
Adverse Effect: sedation |
|
|
Term
|
Definition
acts directly on skeletal muscle, not much on smooth muscle or cardiac, not in CNS
Used for spasticity associated with multiple sclerosis, cerebral palsy, spinal cord injury, BUT CAUSES REDUCTION IN STRENGTH, malignant hyperthermia
Adverse Effects: hepatic toxicity, muscle weakness, drowsiness, diarrhea |
|
|